Press release
Arterial Stents Market Surge to 2035: Growth Driven by Abbott, Boston Scientific, BIOTRONIK & Biosensors
The global arterial stents market is expected to reach USD 61,070 million by 2035, up from USD 19,962 million in 2024. During the forecast period (2025 to 2035), the industry is projected to expand at a CAGR of 10.7%.Browse Full Report: https://www.factmr.com/report/4713/arterial-stents-market
Arterial Stents Market Analysis, By Product, Application, End‐User, and Region
By Product: Coronary Stents vs Peripheral Stents
The arterial stents market is segmented into Coronary Stents and Peripheral Stents. Coronary stents currently dominate, accounting for over 60% of the market share. However, Peripheral Stents are forecasted to grow faster, with an estimated CAGR of 11.8%, compared to 10.0% for coronary devices.
By Application
Arterial stents are used in a range of applications: restoring blood flow in coronary artery disease (CAD), treating peripheral arterial disease (PAD), carotid, femoral and iliac interventions. Coronary artery disease remains the largest application segment, driven by rising global prevalence of hypertension, diabetes, and aging demographics.
By End‐User
Hospitals and cardiac catheterization labs are the primary end‐users of arterial stents, due to the procedural requirements of percutaneous coronary interventions (PCI) and vascular surgeries. Ambulatory surgical centers also play a growing role, particularly in elective peripheral stenting procedures.
By Region
Geographically, North America leads the market, supported by ample healthcare infrastructure, reimbursement mechanisms and early clinical adoption. Asia‐Pacific, led by China and India, is expanding rapidly, while Europe contributes solid market value due to established procedural volume and regulatory structure.
Key Players & Competitive Landscape
Major companies shaping the arterial stents market include Abbott Vascular (Abbott Laboratories), Biosensors International Group, BIOTRONIK AG, Boston Scientific Corporation, and C. R. Bard, Inc. (BARD Peripheral Vascular).
Abbott Vascular has been recognized as a pioneer in bioresorbable stents, being first to receive approval for such platforms in the early 2010s.
Boston Scientific continues to expand its portfolio through acquisitions and new device launches. The company notably acquired BVS Medical in mid‐2023, bolstering its capabilities in advanced stenting technologies.
Biosensors International Group and BIOTRONIK AG focus on innovations in drug‐eluting and biodegradable stent platforms, competing on design differentiation and regional reach.
Other competitive dynamics include Medtronic and Johnson & Johnson (via Cordis), particularly in coronary DES markets. Emerging players are increasingly emphasizing polymer‐free coatings, ultra‐thin struts, and personalized stent designs.
Buy Report - Instant Access: https://www.factmr.com/checkout/4713
Recent Developments & Innovation Highlights
Several recent developments are shaping market momentum:
Innovation in ultra‐thin‐strut drug‐eluting stents (DES), polymer‐free coatings, and improved biocompatibility have raised treatment efficacy while reducing restenosis and thrombosis risks.
Research is advancing asymmetric drug‐eluting stents (ADES), with differential drug loading on inner vs. outer surfaces to accelerate endothelial healing and reduce neointimal proliferation in carotid and coronary vessels.
Studies on design optimization-considering geometry, materials, and patient‐specific anatomy-are paving the way for personalized stent solutions rooted in computational models and machine learning techniques.
Clinically, there is growing evidence supporting drug‐eluting stents over bare‐metal stents (BMS) for both coronary and peripheral interventions due to lower restenosis and improved long‐term outcomes. Moreover, while early bioresorbable devices faced setbacks, newer iterations and competitor products continue to evolve with enhanced safety and efficacy profiles.
Market Drivers & Trends
Several macro‐drivers support sustained expansion:
An ageing global population, combined with rising rates of diabetes, hypertension, obesity and smoking, is increasing cardiovascular disease incidence, and fueling demand for both coronary and peripheral stenting procedures.
A shift from coronary artery bypass grafting (CABG) to percutaneous coronary intervention (PCI) due to faster recovery, lower complication risk and cost‐effectiveness continues to favour stent adoption.
Healthcare access expansion-especially in Asia‐Pacific and parts of Latin America-is improving procedural availability in emerging markets. Investments in interventional cardiology infrastructure and government support in countries like India and China are increasing procedure volumes.
Competitive Outlook & Future Opportunities
Competition among major players is increasingly centered on innovation and differentiation:
Abbott, Boston Scientific, BIOTRONIK, and Biosensors are competing on next‐generation DES platforms, including polymer‐free, biodegradable, and bioresorbable solutions with thinner struts and better drug delivery profiles.
Emerging companies and academic spin‐outs are investing in computationally optimized and patient‐specific stents, leveraging AI and advanced material science.
Strategic partnerships between medical device firms and research institutions are accelerating clinical validation of innovative designs like ADES and smart stents with embedded sensors.
For More Insights into the Market, Request a Sample of this Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=4713
Outlook to 2035: Growth Trajectory & Strategic Implications
With a projected global valuation exceeding USD 61 billion by 2035 and a healthy 10.7% CAGR from 2025 onwards, the arterial stents market offers robust long‐term opportunity. Coronary stents will retain majority share, but peripheral stents are catching up quickly. Growth will be particularly strong in Asia‐Pacific and emerging economies where cardiovascular disease incidence and infrastructure expansion converge to drive demand.
Key strategic imperatives for players include:
Continued investment in R&D for biocompatible, polymer‐free, and bioresorbable platforms.
Focus on patient‐specific design, predictive analytics, and computational optimization to deliver personalized solutions.
Expansion into high‐growth regions-such as China, India, and South-East Asia-through local partnerships, regulatory approvals, and manufacturing investments.
Strengthening clinical partnerships and evidence generation via trials highlighting safety, efficacy, and long‐term outcomes.
Check out More Related Studies Published by Fact.MR Research:
Solid Bleached Board Market: https://www.factmr.com/report/solid-bleached-board-market
Corrugated Octabins Market: https://www.factmr.com/report/corrugated-octabins-market
Coffee Bottle Market: https://www.factmr.com/report/coffee-bottle-market
Hinged Food Containers Market: https://www.factmr.com/report/hinged-food-containers-market
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Sales Team : sales@factmr.com
About Us:
Fact.MR is a distinguished market research company renowned for its comprehensive market reports and invaluable business insights. As a prominent player in business intelligence, we deliver deep analysis, uncovering market trends, growth paths, and competitive landscapes. Renowned for its commitment to accuracy and reliability, we empower businesses with crucial data and strategic recommendations, facilitating informed decision-making and enhancing market positioning.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Arterial Stents Market Surge to 2035: Growth Driven by Abbott, Boston Scientific, BIOTRONIK & Biosensors here
News-ID: 4134953 • Views: …
More Releases from Fact.MR

Polymer Seal Market to Reach USD 21.7 Billion by 2035 | Key Players: Freudenberg …
The global Polymer Seal Market, valued at USD 12.8 billion in 2025, is projected to reach USD 21.7 billion by 2035, driven by a robust CAGR of 5.4%. Fueled by increasing demand for high-performance sealing solutions in aerospace, automotive, construction, and electronics, polymer seals deliver durability, chemical resistance, and temperature stability critical for demanding applications. This press release explores the key drivers, projections, and opportunities shaping this dynamic industry.
Browse for…

Pocket Drones Market to Skyrocket to USD 14,781.2 Million by 2035 | Key Players: …
The global Pocket Drones Market, valued at USD 2,684.5 million in 2025, is projected to soar to USD 14,781.2 million by 2035, driven by a robust CAGR of 18.6%. Fueled by compact designs, advanced features like obstacle avoidance, enhanced camera quality, and extended battery life, pocket drones are transforming aerial photography, recreational use, and commercial applications. This press release explores the key drivers, projections, and opportunities shaping this high-growth industry.
Browse…

Plastic Containers Market to Reach USD 187.3 Billion by 2035 | Key Players: Amco …
The global Plastic Containers Market, valued at USD 112.8 billion in 2025, is projected to reach USD 187.3 billion by 2035, driven by a robust CAGR of 5.2%. Fueled by rising demand for convenient, lightweight packaging in food, beverage, and personal care industries, as well as a surge in e-commerce, plastic containers are critical for durable and cost-effective solutions. This press release explores the key drivers, projections, and opportunities shaping…

Nafion Market is Growing at a CAGR of 5.6% by 2035 | Key Players: The Chemours C …
The global Nafion Market, valued at USD 891.4 million in 2025, is projected to reach USD 1,537.1 million by 2035, driven by a robust CAGR of 5.6%. Fueled by rising demand for proton exchange membranes in fuel cells, hydrogen electrolyzers, and redox flow batteries, Nafion's high ionic conductivity, chemical stability, and durability make it a cornerstone for clean energy technologies. This press release explores the key drivers, projections, and opportunities…
More Releases for Stents
Airway Stents (Lung Stents) Research:CAGR of 6.0% during the forecast period
QY Research Inc. (Global Market Report Research Publisher) announces the release of 2025 latest report "Airway Stent & Lung Stent- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031". Based on current situation and impact historical analysis (2020-2024) and forecast calculations (2025-2031), this report provides a comprehensive analysis of the global Wire Drawing Dies market, including market size, share, demand, industry development status, and forecasts for the next…
Stents Market
Stents Market, Arteriology stents are tubes that are inserted into the coronary artery to open blockages or stenosis. They are used in a process known as coronary angioplasty or percutaneous coronary intervention (PCI).
This method is minimally invasive and is used to treat coronary artery stenosis or narrowing. In the market for cardiac stents globally, technology is crucial. Manufacturers invest much in research and development to create new goods that outperform…
Ureteral Stents
Increasing prevalence of urinary incontinence with age and rising geriatric population are major factors expected to drive the ureteral stents market growth during the forecast period. According to the Global Forum for Incontinence held in 2014, incontinence is a serious medical condition and set of diseases, which affected 4% to 8% of the population or the lives of around 400 million people worldwide over a period of 2007-2010.
Furthermore, lifestyle associated…
Stents Market Demands with Major Types: Coronary Stents, Drug-Eluting Stents (DE …
The “Stents Market Report” gives a clear understanding of the present market condition which includes of historic and projected upcoming Stents industry size, growth, value and volume, projecting cost-effective.
Stents Market - Competitive Insights:
The leading players in the market are Abbott Laboratories, B. Braun Melsungen AG, Boston Scientific Corporation, Elixir Medical Corporation and others. Many Key players are depending on methods, for example, agreements & joint ventures, collaborations, and advancements to…
Intracranial Stents In Global Market: By Application - Self-expandable Stents & …
Researchmoz added Most up-to-date research on "Intracranial Stents In Global Market: By Application - Self-expandable Stents & Balloon-expanded Stents" to its huge collection of research reports.
This report studies Intracranial Stents in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
Medtronic
Stryker
MicroVentionTerumo
Abbott
Balt
Boston Scientific
Obex Medical
DePuy Synthes (Johnson & Johnson)
MicroPort Scientific
Market Segment…
Europe Intracranial Stents Market For 2017: By Application - Self-expandable Ste …
Researchmoz added Most up-to-date research on "Europe Intracranial Stents Market For 2017: By Application - Self-expandable Stents & Balloon-expanded Stents" to its huge collection of research reports.
This report studies sales (consumption) of Intracranial Stents in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering
Medtronic
Stryker
MicroVentionTerumo
Abbott
Balt
Boston Scientific
Obex Medical
DePuy…